Moderna is set to receive $176 million from the U.S. government to develop a mRNA vaccine for bird flu in humans.
The COVID-19 vaccines used mRNA technology.
Moderna is set to receive $176 million from the U.S. government to develop a mRNA vaccine for bird flu in humans.
The COVID-19 vaccines used mRNA technology.